Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
New non-opioid painkiller Journavx approved by FDA
What to Know About Journavx, the Non-Opioid Pain Medication Just Approved by the FDA
The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in more than 20 years.
What Is Journavx, the New Opioid-Free Painkiller from Vertex?
The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment
FDA approves new pain medicine as opioid alternative. What to know about Journavx
The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side effects.
8h
on MSN
New pain drug, Vertex’s Journavx, gets FDA approval as safer alternative to addictive opioids
Each year, about 125 million opioid prescriptions are written for Americans with pain caused by broken bones, burns, ...
10h
on MSN
Brand-new painkiller approved by US health agency
Suzetrigine (Journavx) is the first non-opioid painkiller to be approved in the US in 20 years. It could help over 80 million ...
AFP
16h
Vertex Announces FDA Approval of JOURNAVXâ„¢ (suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Black boxes recovered
New tariffs coming Saturday
Receives $250K settlement
IL won’t hire Jan. 6 rioters
Granted legal personhood
To again run for Senate?
Apologizes for old tweets
Todd exits NBC News
Activists call for boycott
Cause of death revealed
Tour boat captain sentenced
Cancerous tumor removed
Navajo men, partner indicted
Opens probe into NPR, PBS
Top leaders asked to resign
Seeking a new trial
Shiffrin finishes 10th
Ground stop amid IT outage
S3 release date revealed
Nashville bids for franchise
Weekly jobless claims fall
FDA approves painkiller
Partners w/ US national labs
Inmate's transfer blocked
US inflation ticked higher
Confirmed interior secretary
DOJ sues to block deal
'As Tears Go By' singer dies
Olympic gold medalist dies
Recuses self from Act 10 suit
To raise hourly pay
Hamas confirms death
Searching for joyriders
Feedback